Late cytogenetic and molecular response to interferon-α (IFN-α) in chronic myelogenous leukemia (CML).

被引:0
|
作者
Nosari, A
Perego, R
Pungolino, E
Cornacchini, G
Gargantini, L
Morra, E
机构
[1] Niguarda Hosp, Dept Hematol, Milan, Italy
[2] Univ Milan, Inst Gen Pathol, Milan, Italy
[3] Univ Milan, CNR, Ctr Res Cellular Pathol, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2587
引用
收藏
页码:627A / 627A
页数:1
相关论文
共 50 条
  • [41] Interferon-α combined with cytarabine in chronic myelogenous leukemia -: Clinical benefits
    Lindauer, M
    Fischer, T
    [J]. LEUKEMIA & LYMPHOMA, 2001, 41 (5-6) : 523 - 533
  • [42] Interferon-α protects Philadelphia-negative hematopoietic progenitors from exhaustion in chronic myeloid leukemia (CML) patients with cytogenetic response.
    Frassoni, F
    Podestà, M
    Piaggio, G
    Rosti, V
    Pitto, A
    Figari, O
    Soracco, M
    Bergamaschi, G
    Gualandi, F
    Lamparelli, T
    Berisso, G
    Bacigalupo, A
    Cazzola, M
    [J]. BLOOD, 1998, 92 (10) : 250A - 251A
  • [43] Signaling via the interferon-α receptor in chronic myelogenous leukemia cells
    Verma, A
    Platanias, LC
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (04) : 703 - 709
  • [44] PROLONGED SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA AFTER CYTOGENETIC RESPONSE TO INTERFERON-ALPHA THERAPY
    KANTARJIAN, HM
    SMITH, TL
    OBRIEN, S
    BERAN, M
    PIERCE, S
    TALPAZ, M
    ROBERTSON, L
    KOLLER, C
    ESTEY, E
    KEATING, MJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (04) : 254 - 261
  • [45] Low levels of residual disease predict durable cytogenetic remission in chronic myelogenous leukemia patients responding to interferon-α.
    Hochhaus, A
    Reiter, A
    Saussele, S
    Reichert, A
    Emig, M
    Kaeda, J
    Schultheis, B
    Berger, U
    Shepherd, PCA
    Allan, NC
    Hehlmann, R
    Goldman, JM
    Cross, NCP
    [J]. BLOOD, 1999, 94 (10) : 531A - 531A
  • [46] Effect of interferon-alpha (IFN-A) therapy on bone marrow (BM) fibrosis in chronic myelogenous leukemia (CML)
    Wilhelm, M
    Ramos, CM
    OBrien, S
    Pierce, S
    Keating, M
    Talpaz, M
    Kantarjian, H
    [J]. BLOOD, 1996, 88 (10) : 3537 - 3537
  • [47] The long term outcome of the patients with chronic myeloid leukemia (CML) who have achieved complete cytogenetic response (CCgR) to interferon-α (IFNα).: A collaborative European study of 317 cases.
    Bonifazi, F
    De Vivo, A
    Rosti, G
    Guilhot, F
    Guilhot, J
    Trabacchi, E
    Hehlmann, R
    Hochhaus, A
    Shepherd, P
    Steegmann, JL
    Kluin-Nelemans, HC
    Thaler, J
    Simonsson, B
    Louwagie, A
    Reiffers, J
    Mahon, FX
    Montefusco, E
    Alimena, G
    Hasford, J
    Richards, S
    Saglio, G
    Testoni, N
    Martinelli, G
    Tura, S
    Baccarani, M
    [J]. BLOOD, 2001, 98 (11) : 348A - 348A
  • [48] Frequency of molecular elimination of Ph1 clone in chronic myelogenous leukemia (CML) with interferon alpha
    Henic, N
    Preudhomme, C
    Noel, M
    Lai, J
    Wetterwald, M
    Simon, M
    Fenaux, P
    [J]. LEUKEMIA, 1996, 10 (01) : 185 - 186
  • [49] Chronic myeloid leukemia and interferon-α:: a study of complete cytogenetic responders
    Bonifazi, F
    de Vivo, A
    Rosti, G
    Guilhot, F
    Guilhot, J
    Trabacchi, E
    Hehlmann, R
    Hochhaus, A
    Shepherd, PCA
    Steegmann, JL
    Kluin-Nelemans, HC
    Thaler, J
    Simonsson, B
    Louwagie, A
    Reiffers, J
    Mahon, FX
    Montefusco, E
    Alimena, G
    Hasford, J
    Richards, S
    Saglio, G
    Testoni, N
    Martinelli, G
    Tura, S
    Baccarani, M
    [J]. BLOOD, 2001, 98 (10) : 3074 - 3081
  • [50] Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia
    Miglino, Maurizio
    Grasso, Raffaella
    Varaldo, Riccardo
    Fugazza, Giuseppina
    Colombo, Nicoletta
    Clavio, Marino
    Canepa, Letizia
    Garuti, Anna
    Ibatici, Adalberto
    Pierri, Ivana
    Ballerini, Filippo
    Sessarego, Mario
    Gobbi, Marco
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1348 - 1351